Latest news with #EnsignGroup
Yahoo
02-06-2025
- Business
- Yahoo
The Ensign Group Acquires Two Skilled Nursing Facilities in Idaho
SAN JUAN CAPISTRANO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of Ironwood Rehabilitation and Care Center, an 80-bed skilled nursing facility located in Coeur d'Alene, Idaho and Lakeside Rehabilitation and Care Center, a 100-bed skilled nursing facility also located in Coeur d'Alene, Idaho. These acquisitions were effective June 1, 2025 and are subject to a long-term, triple net master lease with a third-party landlord. 'We are excited to add these two facilities to our increasing presence in Idaho,' said Barry Port, Ensign's Chief Executive Officer. 'Coeur d'Alene is an area that we are thrilled to be in and look forward to continued growth around these facilities,' he added. Steve Farnsworth, President of Pennant Healthcare LLC, Ensign's northwest subsidiary, added 'These facilities are a wonderful fit for us both culturally and operationally and there should be a seamless transition bringing them into our local cluster. The caregivers are amazing, and we can't wait to work with them to provide incredible service to our residents and their families.' In a separate transaction on the same day, Ensign announced that it acquired the operations of Toluca Lake Transitional Care, a 52-bed skilled nursing facility located in North Hollywood, California. The real estate will be acquired by a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign's captive real estate company, following receipt of state regulatory approvals. The acquisition was part of the larger acquisition of seven other facilities from Providence Home and Community Care, which was announced in December 2024. These acquisitions were effective as of June 1, 2025, and bring Ensign's growing portfolio to 347 healthcare operations, which includes 44 senior living operations, across 17 states. Ensign subsidiaries, including Standard Bearer, own 144 real estate assets. Mr. Port reaffirmed that Ensign is actively seeking opportunities to acquire real estate and to lease both well-performing and struggling skilled nursing, senior living and other healthcare related businesses throughout the United Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 347 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at Ensign Group, Inc., (949) 487-9500, ir@ SOURCE: The Ensign Group, Inc.
Yahoo
05-05-2025
- Business
- Yahoo
Earnings To Watch: Pediatrix Medical Group (MD) Reports Q1 Results Tomorrow
Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) will be reporting results tomorrow before market hours. Here's what to look for. Pediatrix Medical Group beat analysts' revenue expectations by 3.6% last quarter, reporting revenues of $502.4 million, up 1.2% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts' same-store sales and EPS estimates. Is Pediatrix Medical Group a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Pediatrix Medical Group's revenue to decline 8.9% year on year to $451.1 million, a deceleration from its flat revenue in the same quarter last year. Adjusted earnings are expected to come in at $0.24 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Pediatrix Medical Group has missed Wall Street's revenue estimates four times over the last two years. Looking at Pediatrix Medical Group's peers in the healthcare providers & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. The Ensign Group delivered year-on-year revenue growth of 16.1%, meeting analysts' expectations, and Alignment Healthcare reported revenues up 47.5%, topping estimates by 4.4%. The Ensign Group's stock price was unchanged after the resultswhile Alignment Healthcare was down 7%. Read our full analysis of The Ensign Group's results here and Alignment Healthcare's results here. There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 4.9% on average over the last month. Pediatrix Medical Group is down 1.5% during the same time and is heading into earnings with an average analyst price target of $18.07 (compared to the current share price of $12.94). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. Sign in to access your portfolio
Yahoo
30-04-2025
- Business
- Yahoo
Ensign Group (ENSG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Ensign Group (ENSG) reported $1.17 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 16.1%. EPS of $1.52 for the same period compares to $1.30 a year ago. The reported revenue represents a surprise of +0.23% over the Zacks Consensus Estimate of $1.17 billion. With the consensus EPS estimate being $1.50, the EPS surprise was +1.33%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Ensign Group performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Actual patient days: 2,538,135 compared to the 2,554,506 average estimate based on two analysts. Revenue- Rental revenue: $6 million versus the two-analyst average estimate of $6.60 million. Service Revenue- Skilled Services: $1.12 billion versus the two-analyst average estimate of $1.12 billion. Revenue- Service revenue: $1.17 billion versus $1.16 billion estimated by two analysts on average. View all Key Company Metrics for Ensign Group here>>>Shares of Ensign Group have returned -1.8% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Ensign Group, Inc. (ENSG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
28-04-2025
- Business
- Yahoo
The Ensign Group (ENSG) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare services company The Ensign Group (NASDAQ:ENSG). will be reporting earnings tomorrow after market close. Here's what investors should know. The Ensign Group met analysts' revenue expectations last quarter, reporting revenues of $1.13 billion, up 15.5% year on year. It was a mixed quarter for the company, with sales volume in line with analysts' estimates. Is The Ensign Group a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting The Ensign Group's revenue to grow 16.1% year on year to $1.17 billion, improving from the 13.9% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.49 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. The Ensign Group has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 1.1% on average. Looking at The Ensign Group's peers in the healthcare providers & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Centene delivered year-on-year revenue growth of 15.4%, beating analysts' expectations by 8.3%, and Encompass Health reported revenues up 10.6%, topping estimates by 1.7%. Encompass Health traded up 11.8% following the results. Read our full analysis of Centene's results here and Encompass Health's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 5.6% on average over the last month. The Ensign Group is down 3% during the same time and is heading into earnings with an average analyst price target of $165.80 (compared to the current share price of $125.56). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
Yahoo
09-04-2025
- Business
- Yahoo
2 Reasons to Like ENSG (and 1 Not So Much)
The Ensign Group trades at $123.75 per share and has stayed right on track with the overall market, losing 15.4% over the last six months while the S&P 500 is down 13.9%. This might have investors contemplating their next move. Given the weaker price action, is now an opportune time to buy ENSG? Find out in our full research report, it's free. Founded in 1999 and named after a naval term for a flag-bearing ship, The Ensign Group (NASDAQ:ENSG) operates skilled nursing facilities, senior living communities, and rehabilitation services across 15 states, primarily serving high-acuity patients recovering from various medical conditions. Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful Specialized Medical & Nursing Services company because there's a ceiling to what customers will pay. The Ensign Group's units sold punched in at 2.47 million in the latest quarter, and over the last two years, averaged 14.3% year-on-year growth. This performance was impressive and shows its offerings have a unique value proposition (and perhaps some degree of customer loyalty). We track the long-term change in earnings per share (EPS) because it highlights whether a company's growth is profitable. The Ensign Group's EPS grew at an astounding 19.7% compounded annual growth rate over the last five years, higher than its 15.9% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded. ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity). We like to invest in businesses with high returns, but the trend in a company's ROIC is what often surprises the market and moves the stock price. Unfortunately, The Ensign Group's ROIC has decreased over the last few years. Only time will tell if its new bets can bear fruit and potentially reverse the trend. The Ensign Group's positive characteristics outweigh the negatives. With the recent decline, the stock trades at 20.1× forward price-to-earnings (or $123.75 per share). Is now the right time to buy? See for yourself in our full research report, it's free. Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Sterling Infrastructure (+1,096% five-year return). Find your next big winner with StockStory today for free. Sign in to access your portfolio
